Kensing, LLC , a leading manufacturer of plant-based vitamin E, phytosterols, phytosterol and specialty esters, and high-purity anionic surfactants, and a portfolio company of One Rock Capital Partners, LLC, today announced that it has entered into a definitive agreement to acquire the Hopewell, Virginia amphoteric surfactants and specialty esters manufacturing operations (the “Acquired Operations”) from Evonik Corporation (“Evonik”).

The acquired operations primarily serve the personal care and home care markets in North America, with a focus on skin care, hair care and oral care applications. They are known for product quality and technical leadership, with over 50 years of experience in betaines chemistry.

“The amphoteric surfactants and specialty esters manufacturing operations that Kensing will acquire as a result of this transaction are complementary to our existing product portfolio derived from plant-based feedstocks,” said Serge Rogasik, Chief Executive Officer of Kensing. “With this acquisition, we are building on our leadership position in high-purity anionic surfactants and expanding Kensing’s presence in personal care and home care ingredients. We look forward to providing our customers with an expanded range of low-detergency product and service offerings.”

Rohan Narayan, Partner at One Rock added, “We are excited to support Kensing in its second add-on acquisition. These innovative, high-quality, natural raw material-based products are a great fit for Kensing. We continue to actively support Kensing’s pursuit of acquisition opportunities aimed at further strengthening its position as a leading, global manufacturer of plant-based ingredients.”

The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in the third quarter of 2022.